1. High plasma lipoprotein(A) levels are associated with increased prevalence of cardiovascular disease and poorer metabolic control in patients with type 1 diabetes mellitus. (December 2020) Authors: Littmann, K.; Wodaje, T.; Alvarsson, M.; Bottai, M.; Eriksson, M.; Parini, P.; Brinck, J. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lipoprotein (A) Plasma Levels And Association To Cardiovascular Disease In A Stockholm County Cohort – A Retrospective Observational Cohort Registry Study. (August 2019) Authors: Littmann, K.; Brinck, J.; Eriksson, M.; Parini, P. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Simvastatin and ezetimibe reduce plasma lipoprotein binding to human arterial proteoglycans in gallstone diseased patients. (August 2018) Authors: Littmann, K.; Ahmed, O.; Gustafsson, U.; Pramfalk, C.; Öörni, K.; Larsson, L.; Sahlin, S.; Camejo, G.; Parini, P.; Eriksson, M. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗